Search stocks

Find any stock by ticker or company name

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Watchlist
Markets
Calendar
Screener
News
About

KNSA - Kiniksa Pharmaceuticals... | Finranks

Home

/

KNSA

K

Kiniksa Pharmaceuticals International, plc (KNSA)

NMS – Real Time Price. Currency in USD

79.42

+1.62 (2.08%)

Market open: Aug 12, 2026, 11:15 AM EDT

78.80

+1.00 (1.29%)

Previous after-hours: Aug 11, 2026, 7:58 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Total Assets

Total Liabilities

Stockholders Equity

Total Debt

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

678M

423M

270M

220M

Cost of goods sold

-307M

-190M

-91M

-51M

Gross Profit

370M

234M

179M

169M

Operating expenses (excl. COGS)

-293M

-279M

-204M

-159M

Operating Income

77M

-46M

-25M

10M

Non-operating income, total

12M

9M

9M

1M

Pretax income

89M

-36M

-17M

11M

Equity in earnings

0

0

0

0

Taxes

-30M

-7M

31M

172M

Non-controlling/minority interest

0

0

0

0

After tax other income/expense

0

0

0

0

Net income before discontinued operations

59M

-43M

14M

183M

Discontinued operations

0

0

0

0

Net income

59M

-43M

14M

183M

Dilution adjustment

0

0

0

0

Preferred dividends

0

0

0

0

Name

2025

2024

2023

2022

Total assets

764M+31.5%

581M+10.3%

526M+14.5%

460M

Total current assets

527M

332M

276M

243M

Total non-current assets

236M

249M

250M

217M

Total liabilities

196M+37.9%

142M+62.5%

87M+37.7%

64M

Total current liabilities

139M

101M

64M

47M

Total non-current liabilities

57M

41M

24M

16M

Total equity

568M

438M

439M

396M

Total liabilities & shareholders' equities

764M

581M

526M

460M

Total debt

9M-3.6%

10M-19.6%

12M+107.1%

6M

Name

2025

2024

2023

2022

Cash from operating activities

138M

26M

13M

6M

Cash from investing activities

-189M

38M

-30M

-8M

Cash from financing activities

33M

12M

1M

3M

Free cash flow

136M+436.8%

25M+92.9%

13M+131.0%

6M